Dendritic Cell-based Immunotherapy for the Treatment of Hematological Malignancies

References

• Banchereau, J. and Steinmann, R.M. (1998) "Dendritic cells and the control of immunity", Nature 392, 245–252.
   PubMed Web of Science ®Google Scholar
• Steinman, R.M. (2001) "Dendritic cells and the control of immunity: enhancing the efficiency of antigen presentation", Mt. Sinai J. Med. 68, 106–166.
   PubMedGoogle Scholar
• Suss, G. and Shortman, K. (1996) "A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis", J. Exp. Med. 183, 1789–1796.
   PubMed Web of Science ®Google Scholar
• Maldonado-Lopez, R., De Smedt, T., Pajak, B., Heirman, C., Thielemans, K., Leo, O., Urbain, J., Maliszevski, C.R. and Moser, M. (1999) "Role of CD8alpha+ and CD8alpha— dendritic cells in the induction of primary immune responses in vivo", J. Leukoc. Biol. 66, 242–246.
   PubMed Web of Science ®Google Scholar
• Traver, D., Akashi, K., Manz, M., Merad, M., Miyamoto, T., Engleman, E.G. and Weissman, IL. (2000) "Development of CD8alpha-positive dendritic cells from a common myeloid progenitor", Science 290, 2152–2154.
   PubMed Web of Science ®Google Scholar
• Fearnley, D.B., Whyte, L.F., Carnoutsos, S.A., Cook, A.H. and Hart, D.N.J. (1999) "Monitoring human blood dendritic cell numbers in normal individuals and in stem cell transplanta-tion", Blood 93, 728–736.
   PubMed Web of Science ®Google Scholar
• Keller, R. (2001) "Dendritic cells: their significance in health and disease", Immunol. Lett. 78, 113–122.
   PubMed Web of Science ®Google Scholar
• Arpinati, M., Green, C.L., Heimfeld, S., Heuser, J.E. and Anasetti, C. (2000) "Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells", Blood 95, 2484–2490.
   PubMed Web of Science ®Google Scholar
• Brossart, P., Wirths, S., Brugger, W. and Kanz, L. (2001) "Dendritic cells in cancer vaccines", Exp. Hematol. 29, 1247–1255.
   PubMed Web of Science ®Google Scholar
• Hart, D.N.J. (1997) "Dendritic cells: unique leukocyte populations which control the primary immune response", Blood 90, 3245–3287.
   PubMed Web of Science ®Google Scholar
• Lechmann, M., Krooshoop, D.J., Dudziak, D., Kremmer, E., Kuhnt, C., Figdor, C.C., Schuler, G. and Steinkasserer, A. (2001) "The extracellular domain of CD83 inhibits dendritic cell-mediated T cell stimulation and binds to a ligand on dendritic cells", J. Exp. Med. 194, 1813–1821.
   PubMed Web of Science ®Google Scholar
• del Hoyo, G.M., Martin, P., Vargas, H.H., Ruiz, S., Arias, C.F. and Ardavin, C. (2002) "Characterization of a common precursor population for dendritic cells", Nature 415, 1043–1047.
   PubMed Web of Science ®Google Scholar
• Randolph, G.J., Beaulieu, S., Lebecque, S., Steinman, R.M. and Muller, W.A. (1998) "Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking", Science 282, 480–483.
   PubMed Web of Science ®Google Scholar
• Chow, A., Toomre, D., Garrett, W. and Mellman, I. (2002) "Dendritic cell maturation triggers retrograde MHC class 11 transport from lysosomes to the plasma membrane", Nature 418, 988–994.
   PubMed Web of Science ®Google Scholar
• Montoya, M., Schiavoni, G., Mattei, F., Gresser, I., Belardelli, F., Borrow, P. and Tough, D.F. (2002) "Type I interferons produced by dendritic cells promote their phenotypic and functional activation", Blood 99, 3263–3271.
   PubMed Web of Science ®Google Scholar
• Luft, T., Jefford, M., Luetjens, P., Toy, T., Hochrein, H., Masterman, K.A., Maliszewski, C., Shortman, K., Cebon, J. and Maraskovsky, E. (2002) "Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E(2) regulates the migratory capacity of specific DC subsets", Blood 100, 1362–1372.
   PubMed Web of Science ®Google Scholar
• Muraille, E., De Trez, C., Pajak, B., Brait, M., Urbain, J. and Leo, O. (2002) "T cell-dependent maturation of dendritic cells in response to bacterial superantigens", J. Immunol. 168, 4352–4360.
   PubMed Web of Science ®Google Scholar
• Zheng, H., Dai, J., Stoilova, D. and Li, Z. (2001) "Cell surface targeting of heat shock protein gp96 induces dendritic cell maturation and antitumor immunity", J. Immunol. 167, 6731–6735.
   PubMed Web of Science ®Google Scholar
• Wang, Y., Kelly, C.G., Singh, M., McGowan, E.G., Carrara, A.S., Bergmeier, L.A. and Lehner, T. (2002) "Stimulation of m1-polarizing cytokines, C—C chemokines, maturation of dendritic cells, and adjuvant function by the Peptide binding fragment of heat shock protein 70", J. Immunol. 169, 2422–2429.
   PubMed Web of Science ®Google Scholar
• Vincent, M.S., Leslie, D.S., Gumperz, J.E., Xiong, X., Grant, E.P. and Brenner, M.B. (2002) "CD1-dependent dendritic cell instruction", Nat. Immunol. 3, 1163–1168.
   PubMed Web of Science ®Google Scholar
• Biragyn, A., Ruffini, P.A., Leifer, C.A., Klyushnenkova, E., Shakhov, A., Chertov, O., Shirakawa, A.K., Farber, J.M., Segal, D.M., Oppenheim, J.J. and Kwak, L.W. (2002) "Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2", Science 298, 1025–1029.
   PubMed Web of Science ®Google Scholar
• Le Naour, E, Hohenkirk, L., Grolleau, A., Misek, D.E., Lescure, P., Geiger, J.D., Hanash, S. and Beretta, L. (2001) "Profiling changes in gene expression during differentiation and maturation of monocyte-derived dendritic cells using both oligonucleotide microarrays and proteomics", J. Biol. Chem. 276, 17920–17931.
   PubMed Web of Science ®Google Scholar
• Chen, Z., Dehm, S., Bonham, K., Kamencic, H., Juurlink, B., Zhang, X., Gordon, J.R. and Xiang, J. (2001) "DNA array and biological characterization of the impact of the maturation status of mouse dendritic cells on their phenotype and antitumor vaccination efficacy", Cell Immunol. 214, 60–71.
   PubMed Web of Science ®Google Scholar
• Chen, Z., Gordon, JR., Zhang, X. and Xiang, J. (2002) "Analysis of the gene expression profiles of immature versus mature bone marrow-derived dendritic cells using DNA arrays", Biochem. Biophys. Res. Commun. 290, 66–72.
   PubMed Web of Science ®Google Scholar
• Dieu-Nosjean, M.C., Vicari, A., Lebecque, S. and Caux, C. (1999) "Regulation of dendritic cell trafficking: a process that involves the participation of selective chemoldnes", J. Leukoc. Biol. 66, 252–262.
   PubMed Web of Science ®Google Scholar
• Bianchi, G., D'Amico, G., Varone, L., Sozzani, S., Mantovani, A. and Allavena, P. (2000) "In vitro studies on the trafficking of dendritic cells through endothelial cells and extra-cellular matrix", Dev. Immunol. 7, 143–153.
   PubMedGoogle Scholar
• Mayordomo, J.I., Zorina, T., Storkus, W.J., Zitvogel, L., Celluzzi, C., Falo, L.D., Melief, C.J., Ildstad, ST., Kast, W.M., Deleo, A.B., et al. (1995) "Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity", Nat. Med. 1, 1297–1302.
   PubMed Web of Science ®Google Scholar
• Timmerman, J.M. and Levy, R. (2000) "Linkage of foreign carrier protein to a self-tumor antigen enhances the immunogenicity of a pulsed dendritic cell vaccine", J. Immunol. 164, 4797–4803.
   PubMed Web of Science ®Google Scholar
• Barratt-Boyes, S.M., Watkins, S.C. and Finn, O.J. (1997) "In vivo migration of dendritic cells differentiated in vitro: a chimpanzee model", J. Immunol. 158, 4543–4547.
   PubMed Web of Science ®Google Scholar
• Yi, Q., Desikan, R., Barlogie, B. and Munshi, N. (2002) "Optimizing dendritic cell-based immunotherapy in multiple myeloma", Br. J. Haematol. 117, 297–305.
   PubMed Web of Science ®Google Scholar
• Bender, A., Sapp, M., Schuler, G., Steinman, R.M. and Bhardwaj, N. (1996) "Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood", J. Immunol. Methods 196, 121–135.
   PubMed Web of Science ®Google Scholar
• Romani, N., Reider, D., Heuer, M., Ebner, S., Kampgen, E., Eibl, B., Niederwieser, D. and Schuler, G. (1996) "Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability", J. Immunol. Methods 196, 137–151.
   PubMed Web of Science ®Google Scholar
• Hajek, R. and Butch, A.W. (2000) "Dendritic cell biology and the application of dendritic cells to immunotherapy of multiple myeloma", Med. Oncol. 17, 2–15.
   PubMed Web of Science ®Google Scholar
• Tarte, K., Fiol, G., Rossi, J.F. and Klein, B. (2000) "Extensive characterization of dendritic cells generated in serum-free conditions: regulation of soluble antigen uptake, apoptotic tumor cell phagocytosis, chemotaxis and T cell activation during maturation in vitro", Leukemia 14, 2182–2192.
   PubMed Web of Science ®Google Scholar
• Mackensen, A., Drager, R., Schlesier, M., Mertelsmann, R. and Lindemann, A. (2000) "Presence of IgE antibodies to bovine serum albumin in a patient developing anaphylaxis after vaccination with human peptide-pulsed dendritic cells", Cancer Immunol. Immunother. 49, 152–156.
   PubMed Web of Science ®Google Scholar
• Rachler, T., Hajek, R., Bourkova, L., Kovarova, L., Musilova, R., Bulikova, A., Doubek, M., Svobodnik, A., Mareschova, I., Vanova, P., Tuzova, E., Vidlakova, P., Vorlicek, J. and Penka, M. (2003) "Generation of antigen-loaded dendritic cells in a serum-free medium using different cytokine combinations", Vaccine 21, 877–882.
   PubMed Web of Science ®Google Scholar
• Hsu, F.J., Benike, C., Fagnoni, E, Liles, T.M., Czerwinski, D., Taidi, B., Engleman, E.G. and Levy, R. (1996) "Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells", Nat. Med. 2, 52–58.
   PubMed Web of Science ®Google Scholar
• Maier, T., Kyi, A.T., Dummer, R., Burg, G., et al. (2002) Vaccination of cutaneous T-cell lymphoma patients with intranodal injection of tumor lysate pulsed dendritic cells. Abstract book 7th International Symposium on Dendritic Cells Bamberg, Germany, Sept 19–24, 2002, 81, abstract 162.
   Google Scholar
• Gahn, B., Siller-Lopez, E, Pirooz, A.D., Yvon, E., Gottschalk, S., Longnecker, R., Brenner, M.K., Heslop, HE., Aguilar-Cordova, E. and Rooney, C.M. (2001) "Adenoviral gene transfer into dendritic cells efficiently amplifies the immune response to LMP2A antigen: a potential treatment strategy for Epstein—Barr virus—positive Hodgkin's lymphoma", Int. J. Cancer 93, 706–713.
   PubMed Web of Science ®Google Scholar
• Rooney, CM., Roskrow, MA., Suzuki, N., Ng, C.Y., Brenner, M.K. and Heslop, H. (1998) "Treatment of relapsed Hodgkin's disease using EBV-specific cytotoxic T cells", Ann. Oncol. 9\(Suppl. 5), S129—S132.
   PubMedGoogle Scholar
• Massaia, M., Borrione, P., Battaglio, S., Mariam, S., Beggiato, E., Napoli, P., Voena, C., Bianchi, A., Coscia, M., Besostri, B., Peola, S., Stiefel, T., Even, J., Novero, D., Boccadoro, M. and Pileri, A. (1999) "Idiotype vaccination in human myeloma: generation of tumor-specific immune responses after high-dose chemotherapy", Blood 15, 673–683.
   Google Scholar
• Lynch, R.G., Graff, R.J., Sirisinha, S., Simms, ES. and Eisen, H.N. (1972) "Myeloma proteins as tumor-specific transplan-tation antigens", Proc. Natl Acad. Sci. USA 69, 1540–1544.
   PubMed Web of Science ®Google Scholar
• Bergenbrant, S., Yi, Q., Osterborg, A., Bjorkholm, M., Osby, E., Mellstedt, H., Lefvert, A.K. and Holm, G. (1996) "Modulation of anti-idiotypic immune response by immunization with the autologous M-component protein in multiple myeloma patients", Br. J. Haematol. 92, 840–846.
   PubMed Web of Science ®Google Scholar
• Kwak, LW., Campbell, M.J., Czerwinski, D.K., Hart, S., Miller, R.A. and Levy, R. (1992) "Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors", N. Engl. J. Med. 327, 1209–1215.
   PubMed Web of Science ®Google Scholar
• Osterborg, A., Yi, Q., Henriksson, L., Fagerberg, J., Bergenbrant, S., Jeddi-Tehrani, M., Ruden, U., Lefvert, AK., Holm, G. and Mellstedt, H. (1998) "Idiotype immunization combined with granulocyte-macrophage colony-stimulating factor in myeloma patients induced type I, major histocom-patibility complex-restricted, CD8- and CD4-specific T-cell responses", Blood 91, 2459–2466.
   PubMed Web of Science ®Google Scholar
• Titzer, S., Christensen, O., Manzke, O., Tesch, H., Wolf, J., Emmerich, B., Carsten, C., Diehl, V. and Bohlen, H. (2000) "Vaccination of multiple myeloma patients with idiotype-pulsed dendritic cells: immunological and clinical aspects", Br. J. Haematol. 108, 805–816.
   PubMed Web of Science ®Google Scholar
• Wen, Y.J., Barlogie, B. and Yi, Q. (2001) "Idiotype-specific cytotoxic T lymphocytes in multiple myeloma: evidence for their capacity to lyse autologous primary tumor cells", Blood 97, 1750–1755.
   PubMed Web of Science ®Google Scholar
• Wen, Y.J., Min, R., Tricot, G., Barlogie, B. and Yi, Q. (2002) "Tumor lysate-specific cytotoxic T lymphocytes in multiple myeloma: promising effector cells for immunotherapy", Blood 99, 3280–3285.
   PubMed Web of Science ®Google Scholar
• Zeis, M., Zunkel, T., Steinmann, J., Schmitz, N. and Uharek, L. (2002) "Enhanced antitumoral effectiveness of idiotype vaccination induced by the administration of Flt3 ligand combined with interleukin 2 against a murine myeloma", Br. J. Haematol. 117, 93–102.
   PubMed Web of Science ®Google Scholar
• Reichardt, V.L., Okada, C.Y., Liso, A., Benike, C.J., Stockerl-Goldstein, K.E., Engleman, E.G., Blume, K.G. and Levy, R. (1999) "Idiotype vaccination using dendritic cells after autologous peripheral blood stem cell transplantation for multiple myeloma—a feasibility study", Blood 93, 2411–2419.
   PubMed Web of Science ®Google Scholar
• Liso, A., Stockerl-Goldstein, K.E, Auffermann-Gretzinger, S., Benike, C.J., Reichardt, V., van Beckhoven, A., Rajapaksa, R., Engleman, E.G., Blume, KG. and Levy, R. (2000) "Idiotype vaccination using dendritic cells after autologous peripheral blood progenitor cell transplantation for multiple myeloma", Biol. Blood Marrow Transplant. 6, 621–627.
   PubMed Web of Science ®Google Scholar
• Lim, S.H. and Bailey-Wood, R. (1999) "Idiotypic protein-pulsed dendritic cell vaccination in multiple myeloma", Int. J. Cancer 83, 215–222.
   PubMed Web of Science ®Google Scholar
• Cull, G., Durrant, L., Stainer, C., Haynes, A. and Russell, N. (1999) "Generation of anti-idiotype immune responses following vaccination with idiotype-protein pulsed dendritic cells in myeloma", Br. J. Haematol. 107, 648–655.
   PubMed Web of Science ®Google Scholar
• MacKenzie, M., Strang, G., Peshwa, M., Sopapan, J. and Valone, F. (1998) "Phase Iflit trial of immunotherapy with idiotype-loaded autologous dendritic cells (APC8020) for refractory multiple myeloma", Blood 92\(Suppl. 1), 108a, Abstract.
   Google Scholar
• Ishisaka, T., Nevin, B., Valone, F.H., Kothari, S.S. and Peshwa, UV. (2001) Comparison of Cryopreserved Versus Fresh Formulation of Idiotype-Loaded Autologous Dendritic Cell Vaccine. Program and abstracts of the 43rd Annual Meeting of the American Society of Hematology; December 7–11, 2001; Orlando, Florida. Abstract 4989.
   Google Scholar
• Biichler, T. and Hajek, R. (2002) "Dendritic cell vaccines in the treatment of multiple myeloma—advances and limitations", Med. Oncol. 19, 213–218.
   PubMed Web of Science ®Google Scholar
• Ruffini, PA. and Kwak, LW. (2001) "Immunotherapy of multiple myeloma", Semin. Hematol. 38, 260–267.
   PubMed Web of Science ®Google Scholar
• Brown, RD., Pope, B., Murray, A., Esdale, W., Sze, D.M., Gibson, J., Ho, P.J., Hart, D. and Joshua, D. (2001) "Dendritic cells from patients with myeloma are numerically normal but functionally defective as they fail to up-regulate CD80 (B7-1) expression after huCD4OLT stimulation because of inhibition by transforming growth factor-beta1 and interleukin-10", Blood 98, 2992–2998.
   PubMed Web of Science ®Google Scholar
• Ratta, M., Fagnoni, F., Curti, A., Vescovini, R., Sansoni, P., Oliviero, B., Fogli, M., Fern, E., Della Cuna, G.R., Tura, S., Baccarani, M. and Lemoli, R.M. (2002) "Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6", Blood 100, 230–237.
   PubMed Web of Science ®Google Scholar
• Choudhury, A., Gajewski, J.L., Liang, J.C., Popat, U., Claxton, D.F., Kliche, K.O., Andreeff, M. and Champlin, R.E. (1997) "Use of leukemic dendritic cells for the generation of antileukemic cellular cytotoxicity against Philadelphia chromosome-positive chronic myelogenous leukemia", Blood 89, 1133–1142.
   PubMed Web of Science ®Google Scholar
• Charbonnier, A., Gaugler, B., Sainty, D., Lafage-Pochitaloff, M. and Olive, D. (1999) "Human acute myeloblastic leukemia cells differentiate in vitro into mature dendritic cells and induce the differentiation of cytotoxic T cells against autologous leukemias", Fur. J. Immunol. 29, 2567–2578.
   Web of Science ®Google Scholar
• Oehler, L., Berer, A., Keil, F., Weinlander, G., Konig, M., Haas, O.A., Lechner, K. and Geissler, K. (2000) "Generation of dendritic cells from human chronic myelomonocytic leuke-mia cells in fetal calf serum-free medium", Leuk. Lymphoma 38, 577–586.
   PubMed Web of Science ®Google Scholar
• Collins, Jr., R.H., Shpilberg, O., Drobyski, W.R., Porter, DI., Giralt, S., Champlin, R., Goodman, S.A., Wolff, S.N., Hu, W., Verfaillie, C., List, A., Dalton, W., Ognoskie, N., Chetrit, A., Antin, J.H. and Nemunaitis, J. (1997) "Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation", J. Clin. Oncol. 15, 433–444.
   PubMed Web of Science ®Google Scholar
• Claxton, D.F., McMannis, J., Champlin, R. and Choudhury, A. (2001) "Therapeutic potential of leukemia-derived dendritic cells: preclinical and clinical progress", Crit. Rev. Immunol. 21, 147–155.
   PubMed Web of Science ®Google Scholar
• Mohty, M., Isnardon, D., Blaise, D. et al. (2002) Blood dendritic cells from acute and chronic myeloid leukemia patients display quantitative as well as functional impairment. Abstract book 7th International Symposium on Dendritic Cells Bamberg, Germany, Sept 19–24, 2002. Page 67 (abstr 106).
   Google Scholar
• Strunk, D., Grube, R., Stadelmeyer, E., Chraust, S. and Linkesch, W. (2002) Early dendritic cell deficiency in chronic lymphocytic leukemia. Abstract book 7th International Sym-posium on Dendritic Cells Bamberg, Germany, Sept 19-24, 2002. Page 88 (a 189).
   Google Scholar
• Finkelman, F.D., Lees, A., Birnbaum, R., Gause, W.C. and Morris, S.C. (1996) "Dendritic cells can present antigen in vivo in a tolerogenic or immunogenic fashion", J. Immunol. 157, 1406–1414.
   PubMed Web of Science ®Google Scholar
• Grohmann, U., Bianchi, R., Ayroldi, E., Belladonna, ML., Surace, D., Fioretti, M.C. and Puccetti, P. (1997) "A tumor-associated and self antigen peptide presented by dendritic cells may induce T cell anergy in vivo, but IL-12 can prevent or revert the anergic state", J. Immunol. 158, 3593–3602.
   PubMed Web of Science ®Google Scholar
• Roskrow, MA., Dilloo, D., Suzuki, N., Zhong, W., Rooney, C.M. and Brenner, M.K. (1999) "Autoimmune disease induced by dendritic cell immunization against leukemia", Leuk. Res. 23, 549–557.
   PubMed Web of Science ®Google Scholar
• Ludewig, B., Ochsenbein, A.F., Odermatt, B., Paulin, D., Hengartner, H. and Zinkernagel, R.M. (2000) "Immunothe-rapy with dendritic cells directed against tumor antigens shared with normal host cells results in severe autoimmune disease", J. Exp. Med. 191, 795–804.
   PubMed Web of Science ®Google Scholar
• Keilholz, U. (2002) "Immune monitoring and Vaccine Development", ASCO Educational Book 2002, 184–189.
   Google Scholar
• Foss, F.M. (2002) "Immunologic mechanisms of antitumor activity", Semin. Oncol. 29(Suppl. 7), 5–11.
   PubMedGoogle Scholar
• Igney, F.H. and Krammer, P.H. (2002) "Immune escape of tumors: apoptosis resistance and tumor counterattack", J. Leukoc. Biol. 71, 907–920.
   PubMed Web of Science ®Google Scholar
• Rosenberg, S.A. (2001) "Progress in human tumour immu-nology and immunotherapy", Nature 411, 380–384.
   PubMed Web of Science ®Google Scholar
• Sampalo, A. and Brieva, J.A. (2002) "Humoral immunode-ficiency in chronic lymphocytic leukemia: role of CD95/CD95L in tumoral damage and escape", Leuk. Lymphoma 43, 881–884.
   PubMed Web of Science ®Google Scholar
• Ohashi, T., Hanabuchi, S., Suzuki, R., Kato, H., Masuda, T. and Kannagi, M. (2002) "Correlation of major histocompa-tibility complex class I downregulation with resistance of human T-cell leukemia virus type 1-infected T cells to cytotoxic T-lymphocyte killing in a rat model", J. Virol. 76, 7010–7019.
   PubMed Web of Science ®Google Scholar
• Schultze, J.L. (1999) "Why do B cell lymphoma fail to elicit clinically sufficient T cell immune responses?", Leuk. Lymphoma 32, 223–236.
   PubMed Web of Science ®Google Scholar
• Frassanito, M.A., Cusmai, A. and Dammacco, E (2001) "Deregulated cytokine network and defective Th1 immune response in multiple myeloma", Clin. Exp. Immunol. 125, 190–197.
   PubMed Web of Science ®Google Scholar
• Moingeon, P. (2001) "Cancer vaccines", Vaccine 19, 1305–1326.
   PubMed Web of Science ®Google Scholar
• Laus, R., Graddis, T.J., Hakim, I. and Vidovic, D. (2000) "Enhanced major histocompatibility complex class I-dependent presentation of antigens modified with cationic and fusogenic peptides", Nat. Biotechnol. 18, 1269–1272.
   PubMed Web of Science ®Google Scholar
• Rea, D., Johnson, M.E., Havenga, M.J., Melief, C.J. and Offringa, R. (2001) "Strategies for improved antigen delivery into dendritic cells", Trends Mol. Med. 7, 91–94.
   PubMed Web of Science ®Google Scholar
• Irvine, A.S., Trinder, P.K., Laughton, D.L., Ketteringham, H., McDermott, R.H., Reid, S.C., Haines, A.M., Amir, A., Husain, R., Doshi, R., Young, L.S. and Mountain, A. (2000) "Efficient nonviral transfection of dendritic cells and their use for in vivo immunization", Nat. Biotechnol. 18, 1273–1278.
   PubMed Web of Science ®Google Scholar
• Dhodapkar, K.M., Krasovsky, J., Williamson, B. and Dhodapkar, M.V. (2002) "Antitumor monoclonal antibodies enhance cross-presentation of cellular antigens and the generation of myeloma-specific killer T cells by dendritic cells", J. Exp. Med. 195, 125–133.
   PubMed Web of Science ®Google Scholar
• Spisek, R., Chevallier, P., Morineau, N., Milpied, N., Avet-Loiseau, H., Harousseau, J.L., Meflah, K. and Gregoire, M. (2002) "Induction of leukemia-specific cytotoxic response by cross-presentation of late-apoptotic leukemic blasts by autologous dendritic cells of nonleukemic origin", Cancer Res. 62, 2861–2868.
   PubMed Web of Science ®Google Scholar
• Liu, K., Iyoda, T., Saternus, M., Kimura, Y., Inaba, K. and Steinman, R.M. (2002) "Immune tolerance after delivery of dying cells to dendritic cells in situ", J. Exp. Med. 196, 1091–1097.
   PubMed Web of Science ®Google Scholar
• Merad, M., Sugie, T., Engleman, E.G. and Fong, L. (2002) "In vivo manipulation of dendritic cells to induce therapeutic immunity", Blood 99, 1676–1682.
   PubMed Web of Science ®Google Scholar